Latest bladder cancer News

Ludwig MSK study modeling tumor evolution reveals vulnerability for cancer prevention and therapy
Farxiga met primary endpoint in DELIVER Phase III trial, reducing risk of cardiovascular death or worsening heart failure
AstraZeneca and Neurimmune close exclusive global collaboration and licence agreement to develop and commercialise NI006
Transparent ultrasound chip improves cell stimulation and imaging
World-first trial of targeted bladder cancer treatment showing promise
USANZ and RACGP speak out on pharmacy pilot
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
AstraZeneca and Neurimmune sign exclusive global collaboration and licence agreement to develop and commercialise NI006
Scientists studying new method to model bladder cancer treatments
Cancer survival rates are improving in Australia
Cancer survival rates continue to improve, while death and incidence rates fall
2022 Fellowships to support improved health outcomes for cancer patients
AZD8601 EPICCURE Phase II trial demonstrated safety and tolerability in patients with heart failure
Tonsley takes Flinders on steep learning curve
Heartburn treatment a poor match to cancer drug
Antibiotic overuse reduces bladder cancer survival
Next-gen nano technologies to tackle infection and diagnose disease
Testing tuberculosis vaccine for COVID-19
Frontline Heroes Join Vaccine Trial to Boost COVID-19 Health Defence
Local Coolbinia resident donates $25,000 for cancer patient transport van
Modified tuberculosis vaccine as a therapy for cancer of bladder
Lifting lid on a hidden cancer